Getting Regenerative Medical Biotech REDI to Age
让再生医学生物技术 REDI 走向老龄化
基本信息
- 批准号:10685393
- 负责人:
- 金额:$ 15.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AcademiaAcademic Medical CentersAchievementAddressAfrican AmericanAgeAsian AmericansAwardBiotechnologyBusinessesCaucasiansCellsClinicalCommunitiesComplementContinuing EducationCore FacilityDedicationsDevelopmentDiverse WorkforceEconomic DevelopmentEducational CurriculumEducational process of instructingElementsEmployeeEmployment OpportunitiesEntrepreneurshipEthicsExposure toFoundationsFundingFutureGoalsGood Manufacturing ProcessGrowthHispanic AmericansHumanHuman ResourcesImmersionIncubatorsIndividualIndustryIntentionInternshipsLaboratoriesLearningLouisianaMedicalMethodsMiddle EasternMinorityModelingOrganizational CultureOutcomePathway interactionsPerceptionPersonal GrowthPositioning AttributePrivatizationRegenerative MedicineResearchResearch InstituteResearch PersonnelRoleScienceScientistSmall Business Innovation Research GrantStudentsTherapeuticTissuesTrainingTraining ProgramsUniversitiesWomanWorkcareerclinical translationcommercializationcommunity collegecostcurriculum developmentdemographicsdesignhigh standardinnovationinsightlaboratory facilitymanufacturenext generationoperationprogramsrecruitregenerativeregenerative therapyresponsible research conductsuccesstool
项目摘要
The potential outcomes of this application include: (1) Curriculum development and the creation of internship opportunities within an entrepreneurship in biotechnology focused program; (2) a greater representation of diverse researchers within biotech entrepreneurship in Southeast Louisiana with the potential to expand across the U.S.; (3) a tangible number of students from diverse backgrounds who can go on to pursue advance degrees and employment opportunities within the biotechnology sector; and (4) a pipeline of individuals who will value the importance of the responsible conduct of research, and apply those ethics to create their own companies as entrepreneurs, or their own training programs as educators or researchers within various biotechnology fields. This Small Business Innovation Research application addresses an identified challenge and unmet gap in curriculum development that combines exposure to fundamental concepts in both biotechnology research and entrepreneurial development and provides a pathway to create opportunities for a more diverse workforce. Unlike existing curricula, the proposed programming does not have the goal of promoting careers exclusively in academia or biotechnology. The intention is to leverage the diverse background and training of professionals at Obatala Sciences, Delgado Community College, Xavier University of Louisiana, and the University of New Orleans, to give students greater insight into the opportunities that exist and the relevance of maintaining the responsible conduct of research within all stages of their career. Such a program is a complement to any set of traditional business and/or research courses and provides a mechanism to reinforce some of the necessary elements of success within research in biotechnology and entrepreneurship. Obatala anticipates achievement of the following outcomes: Firstly, it will implement coursework and accompanying teaching tools that focus on entrepreneurship in biotechnology and are adaptable across multiple teaching platforms and programs that are designed to give greater exposure to opportunities in entrepreneurship. Secondly, it will create a pipeline of interns and professionals who can apply lessons learned from their executive MBA or entrepreneurship programs to multiple facets of their careers and take these fundamentals with them to other opportunities throughout the nation. Thirdly, it will create a success metric that can be applied to programs that are designed to promote diversity in research and entrepreneurship. By incorporating one or all of these innovations to the current approach to teaching biotechnology, Obatala will introduce an adaptable teaching model with impacts spanning academic and industry researchers and entrepreneurs, across fields including therapeutics and regenerative medicine. Obatala will position itself as a leader that not only promotes diversity in research, but also in training the next generation of researchers and promoting the highest standards of ethics and the responsible conduct of research. Such activity has potential to positively impact the current perception of the role of entrepreneurship in research in a global scale.
该应用程序的潜在结果包括:(1)课程开发和以生物技术为中心计划的企业家精神的实习机会; (2)在路易斯安那州东南部生物技术企业家精神中的各种研究人员的代表性更大,有可能在整个美国扩展; (3)有许多来自不同背景的学生可以继续在生物技术领域获得提前学位和就业机会; (4)个人将重视负责任的研究重要性的个人,并运用这些道德规范以创建自己的公司为企业家,或者是自己作为各种生物技术领域的教育者或研究人员自己的培训计划。这项小型企业创新研究应用程序解决了课程开发中确定的挑战和未满足的差距,该挑战结合了生物技术研究和企业家开发的基本概念的接触,并为更多样化的劳动力创造了机会。与现有课程不同,拟议的编程没有目的是仅促进学术界或生物技术的职业。目的是利用奥巴塔拉科学,德尔加多社区学院,路易斯安那州泽维尔大学和新奥尔良大学的各种背景和培训,以使学生更深入地了解存在的机会以及在职业生涯中保持负责任的研究的相关性。这样的计划是对任何一系列传统业务和/或研究课程的补充,并提供了一种加强生物技术和企业家研究中成功的必要要素的机制。奥巴塔拉(Obatala)预计将实现以下成果:首先,它将实施着专注于生物技术企业家精神的课程和随附的教学工具,并且在多个教学平台和计划中都可以适应,这些平台和计划旨在使企业家精神的机会更大。其次,它将创建一条实习生和专业人士的管道,他们可以将其从执行MBA或企业家计划中学到的经验教训到其职业生涯的多个方面,并将这些基本面带给全国其他机会。第三,它将创建一个成功指标,该指标可应用于旨在促进研究和企业家精神多样性的计划。通过将一种或所有这些创新纳入当前的生物技术教学方法,Obatala将引入一种适应性的教学模型,影响跨越学术和行业研究人员和企业家的影响,包括治疗和再生医学。奥巴塔拉(Obatala)将自己定位为领导者,不仅促进了研究的多样性,而且还将培训下一代研究人员并促进最高的道德标准和负责任的研究行为。这种活动有可能积极影响当前对企业家精神在全球范围内研究中作用的看法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Trivia Frazier其他文献
Trivia Frazier的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Trivia Frazier', 18)}}的其他基金
Getting Regenerative Medical Biotech REDI to Age
让再生医学生物技术 REDI 走向老龄化
- 批准号:
10502028 - 财政年份:2022
- 资助金额:
$ 15.02万 - 项目类别:
相似海外基金
Getting Regenerative Medical Biotech REDI to Age
让再生医学生物技术 REDI 走向老龄化
- 批准号:
10502028 - 财政年份:2022
- 资助金额:
$ 15.02万 - 项目类别:
Research Project 1: Coronavirus antiviral lead development and combination testing
研究项目1:冠状病毒抗病毒先导药物开发和组合测试
- 批准号:
10513684 - 财政年份:2022
- 资助金额:
$ 15.02万 - 项目类别:
TB Clinical Research: Training the Next Generation
结核病临床研究:培训下一代
- 批准号:
7208039 - 财政年份:2004
- 资助金额:
$ 15.02万 - 项目类别:
TB Clinical Research: Training the Next Generation
结核病临床研究:培训下一代
- 批准号:
7390287 - 财政年份:2004
- 资助金额:
$ 15.02万 - 项目类别: